According to the Washington Post, 13 states currently cover the drugs for Medicaid patients, while Medicare prohibits ...

The Trump administration is planning an experiment to cover weight-loss drugs under Medicare and Medicaid, the Washington ...

The Washington Post editorial board argued a federal judge's ruling against congressional Medicaid restrictions on abortion ...

The vice president is pitching the Trump administration’s signature policy achievement to a skeptical American public.

Republican National Committee Chairman Michael Whatley has launched his campaign for North Carolina’s open U.S. Senate seat ...

In today’s edition … Why young men turned to Trump ... Things are heating up in North Carolina … And you give us your ...

The federal government is expected to start a 5-year-long experiment that will provide some limited coverage of obesity ...

Proposed experiment would allow states and Medicare drug plans to cover GLP-1 drugs like Ozempic and Wegovy for obesity, The ...

The groups that pushed for Planned Parenthood to lose Medicaid reimbursement remain confident that a federal judge's ruling ...

A five-year experiment aims to open access to blockbuster GLP‑1 drugs for obesity, something advocates have pushed for years.

The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...

The Washington Post reported the CMS is considering a plan that could allow Medicare plans to pay for the drugs.